MDPI and ACS Style
Dieci, M.V.; Del Mastro, L.; Cinquini, M.; Montemurro, F.; Biganzoli, L.; Cortesi, L.; Zambelli, A.; Criscitiello, C.; Levaggi, A.; Conte, B.;
et al. Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM). Cancers 2019, 11, 1137.
https://doi.org/10.3390/cancers11081137
AMA Style
Dieci MV, Del Mastro L, Cinquini M, Montemurro F, Biganzoli L, Cortesi L, Zambelli A, Criscitiello C, Levaggi A, Conte B,
et al. Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM). Cancers. 2019; 11(8):1137.
https://doi.org/10.3390/cancers11081137
Chicago/Turabian Style
Dieci, Maria Vittoria, Lucia Del Mastro, Michela Cinquini, Filippo Montemurro, Laura Biganzoli, Laura Cortesi, Alberto Zambelli, Carmen Criscitiello, Alessia Levaggi, Benedetta Conte,
and et al. 2019. "Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)" Cancers 11, no. 8: 1137.
https://doi.org/10.3390/cancers11081137
